People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Perosphere Inc. | — | Pharmaceuticals | Series A | $9.4M | $192.4M | 2011 |
Philip N. Sussman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philip N. Sussman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Erik E. Steiner | 1 | 1 |
| Solomon S. Steiner | 1 | 1 |
| Peter E. Van Straelen | 1 | 1 |
| James C. Costin | 1 | 1 |
| Bryan E. Laulicht | 1 | 1 |
| Charles A. Steiner | 1 | 1 |
| Andreas S. Pfutzner | 1 | 1 |
| Sasha H. Bakhru | 1 | 1 |
| Edith S. Mathiowitz | 1 | 1 |
| R. Timmis Ware | 1 | 1 |
| Charles S. Steiner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.